Fatal S. aureus hemorrhagic pneumonia: genetic analysis of a unique clinical isolate producing both PVL and TSST-1

Zhi Li1, Dennis L Stevens, Stephanie M Hamilton

  • 1Veterans Affairs Medical Center, Boise, Idaho, United States of America. lizhi_lily@hotmail.com

Plos One
|November 24, 2011
PubMed

Insights

A rare Staphylococcus aureus strain producing Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1) was identified. These toxin genes are carried on a novel phage and pathogenicity island, raising concerns about emerging hypervirulent strains.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Staphylococcus aureus can cause severe infections.
  • Co-production of Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1) by S. aureus is uncommon.
  • A fatal case of necrotizing pneumonia was linked to an unusual MSSA strain.

Purpose of the Study:

  • To investigate the molecular organization of PVL and TSST-1 genes in the identified MSSA strain (MSSA68111).
  • To understand the genetic elements responsible for co-production of these toxins.
  • To assess the potential for emergence of hypervirulent S. aureus strains.

Main Methods:

  • Molecular characterization of toxin gene organization.
  • Phylogenetic analysis of phage and staphylococcal pathogenicity island (SaPI).
  • Assessment of transmissibility of genetic elements.

Main Results:

  • The PVL genes were located on a novel temperate prophage, ФPVLv68111, similar to the rare ФPVL phage.
  • The TSST-1 gene was found on a unique SaPI, SaPI68111, likely resulting from recombination.
  • Both genetic elements, ФPVLv68111 and SaPI68111, are mobilizable and transmissible.

Conclusions:

  • The co-production of PVL and TSST-1 in MSSA68111 is mediated by distinct, mobilizable genetic elements.
  • These findings highlight the potential for the emergence and global spread of hypervirulent S. aureus strains.
  • Further surveillance is warranted to monitor the dissemination of such toxin-encoding mobile genetic elements.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...